Brivaracetam Impurity 30 | CAS 63095-60-3 - Request Quote
Brivaracetam Impurity 30
| SZ CAT No: | SZ-B039041 |
| CAS No | 63095-60-3 |
| Mol.F. | C7H12O2 |
| Mol.Wt. | 128.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Brivaracetam Impurity 30 is chemically (S)-4-propyldihydrofuran-2(3H)-one. Brivaracetam Impurity 30 is supplied with detailed characterization data compliant with regulatory guideline. Brivaracetam Impurity 30 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Brivaracetam.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 63095-60-3
Purchase 63095-60-3
Order 63095-60-3
Enquire 63095-60-3
price of 63095-60-3
63095-60-3 Supplier
63095-60-3 Manufacturer
63095-60-3 Exporter
buy high quality Brivaracetam Impurity 30
Purchase Brivaracetam Impurity 30
Brivaracetam Impurity 30 suppliers
Brivaracetam Impurity 30 manufacturers
Brivaracetam Impurity 30 price
Order Brivaracetam Impurity 30
Enquire Brivaracetam Impurity 30
Brivaracetam Impurity 30 cost
Brivaracetam Impurity 30 Supplier
Brivaracetam Impurity 30 Distributor
Brivaracetam Impurity 30 for Method Validation
Brivaracetam Reference Standard
Brivaracetam Impurity 30 for ANDA Filing
Brivaracetam Impurity 30 for Forced Degradation Studies
Brivaracetam Impurity 30 Identification Standards
Brivaracetam Impurity 30 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


